Velocity is collaborating with Merck to explore a new way to engage communities about clinical research. Starting this month the Velocity team members are conducting a tour of several Southern California cities, using Merck's iLab53, a state-of-the-art, modular 39-foot mobile research unit to reach underserved communities.
At each stop, the mobile research unit will serve as a hub for community health screenings and a source for information about clinical research. Following the initial pilot phase in Southern California, Velocity plans to extend the program to additional communities across the US.
This pioneering initiative aligns with Velocity's ongoing commitment to promote diversity in clinical research, improve health equity, and facilitate greater accessibility to clinical trials.
